Literature DB >> 24443827

Extensive brain structural network abnormality in first-episode treatment-naive patients with schizophrenia: morphometrical and covariation study.

Z Chen1, W Deng1, Q Gong2, C Huang1, L Jiang1, M Li1, Z He1, Q Wang1, X Ma1, Y Wang1, S E Chua3, G M McAlonan3, P C Sham3, D A Collier4, P McGuire5, T Li1.   

Abstract

BACKGROUND: Alterations in gray matter (GM) are commonly observed in schizophrenia. Accumulating studies suggest that the brain changes associated with schizophrenia are distributed rather than focal, involving interconnected networks of areas as opposed to single regions. In the current study we aimed to explore GM volume (GMV) changes in a relatively large sample of treatment-naive first-episode schizophrenia (FES) patients using optimized voxel-based morphometry (VBM) and covariation analysis.
METHOD: High-resolution T1-weighted images were obtained using 3.0-T magnetic resonance imaging (MRI) from 86 first-episode drug-naive patients with schizophrenia and 86 age- and gender-matched healthy volunteers. Symptom severity was evaluated using the Positive and Negative Syndrome Scale (PANSS). GMV was assessed using optimized VBM and in 16 regions of interest (ROIs), selected on the basis of a previous meta-analysis. The relationships between GMVs in the ROIs were examined using an analysis of covariance (ANCOVA).
RESULTS: The VBM analysis revealed that first-episode patients showed reduced GMV in the hippocampus bilaterally. The ROI analysis identified reductions in GMV in the left inferior frontal gyrus, bilateral hippocampus and right thalamus. The ANCOVA revealed different patterns of regional GMV correlations in patients and controls, including of inter- and intra-insula, inter-amygdala and insula-postcentral gyrus connections.
CONCLUSIONS: Schizophrenia involves regional reductions in GMV and changes in GMV covariance in the insula, amygdala and postcentral gyrus. These findings were evident at the onset of the disorder, before treatment, and therefore cannot be attributable to the effects of chronic illness progression or medication.

Entities:  

Mesh:

Year:  2014        PMID: 24443827     DOI: 10.1017/S003329171300319X

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  11 in total

Review 1.  Glutamate-mediated excitotoxicity in schizophrenia: a review.

Authors:  Eric Plitman; Shinichiro Nakajima; Camilo de la Fuente-Sandoval; Philip Gerretsen; M Mallar Chakravarty; Jane Kobylianskii; Jun Ku Chung; Fernando Caravaggio; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

Review 2.  Using human brain imaging studies as a guide toward animal models of schizophrenia.

Authors:  S S Bolkan; F Carvalho Poyraz; C Kellendonk
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

3.  Morphological changes in gray matter volume correlate with catechol-O-methyl transferase gene Val158Met polymorphism in first-episode treatment-naïve patients with schizophrenia.

Authors:  Ming-Li Li; Bo Xiang; Yin-Fei Li; Xun Hu; Qiang Wang; Wan-Jun Guo; Wei Lei; Chao-Hua Huang; Lian-Sheng Zhao; Na Li; Hong-Yan Ren; Hui-Yao Wang; Xiao-Hong Ma; Wei Deng; Tao Li
Journal:  Neurosci Bull       Date:  2015-01-06       Impact factor: 5.203

Review 4.  Structural covariance networks in schizophrenia: A systematic review Part I.

Authors:  Konasale Prasad; Jonathan Rubin; Anirban Mitra; Madison Lewis; Nicholas Theis; Brendan Muldoon; Satish Iyengar; Joshua Cape
Journal:  Schizophr Res       Date:  2021-12-11       Impact factor: 4.939

5.  A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium.

Authors:  Boris A Gutman; Theo G M van Erp; Kathryn Alpert; Christopher R K Ching; Dmitry Isaev; Anjani Ragothaman; Neda Jahanshad; Arvin Saremi; Artemis Zavaliangos-Petropulu; David C Glahn; Li Shen; Shan Cong; Dag Alnaes; Ole Andreas Andreassen; Nhat Trung Doan; Lars T Westlye; Peter Kochunov; Theodore D Satterthwaite; Daniel H Wolf; Alexander J Huang; Charles Kessler; Andrea Weideman; Dana Nguyen; Bryon A Mueller; Lawrence Faziola; Steven G Potkin; Adrian Preda; Daniel H Mathalon; Juan Bustillo; Vince Calhoun; Judith M Ford; Esther Walton; Stefan Ehrlich; Giuseppe Ducci; Nerisa Banaj; Fabrizio Piras; Federica Piras; Gianfranco Spalletta; Erick J Canales-Rodríguez; Paola Fuentes-Claramonte; Edith Pomarol-Clotet; Joaquim Radua; Raymond Salvador; Salvador Sarró; Erin W Dickie; Aristotle Voineskos; Diana Tordesillas-Gutiérrez; Benedicto Crespo-Facorro; Esther Setién-Suero; Jacqueline Mayoral van Son; Stefan Borgwardt; Fabienne Schönborn-Harrisberger; Derek Morris; Gary Donohoe; Laurena Holleran; Dara Cannon; Colm McDonald; Aiden Corvin; Michael Gill; Geraldo Busatto Filho; Pedro G P Rosa; Mauricio H Serpa; Marcus V Zanetti; Irina Lebedeva; Vasily Kaleda; Alexander Tomyshev; Tim Crow; Anthony James; Simon Cervenka; Carl M Sellgren; Helena Fatouros-Bergman; Ingrid Agartz; Fleur Howells; Dan J Stein; Henk Temmingh; Anne Uhlmann; Greig I de Zubicaray; Katie L McMahon; Margie Wright; Derin Cobia; John G Csernansky; Paul M Thompson; Jessica A Turner; Lei Wang
Journal:  Hum Brain Mapp       Date:  2021-09-08       Impact factor: 5.399

Review 6.  Role of NG2 expressing cells in addiction: a new approach for an old problem.

Authors:  Sucharita S Somkuwar; Miranda C Staples; Melissa H Galinato; McKenzie J Fannon; Chitra D Mandyam
Journal:  Front Pharmacol       Date:  2014-12-19       Impact factor: 5.810

7.  Volume alteration of hippocampal subfields in first-episode antipsychotic-naïve schizophrenia patients before and after acute antipsychotic treatment.

Authors:  Wenbin Li; Kaiming Li; Pujun Guan; Ying Chen; Yuan Xiao; Su Lui; John A Sweeney; Qiyong Gong
Journal:  Neuroimage Clin       Date:  2018-07-10       Impact factor: 4.881

8.  Small-world properties of brain morphological characteristics in Anorexia Nervosa.

Authors:  Enrico Collantoni; Paolo Meneguzzo; Elena Tenconi; Renzo Manara; Angela Favaro
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

9.  Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.

Authors:  A Batalla; N Bargalló; P Gassó; O Molina; D Pareto; S Mas; J M Roca; M Bernardo; A Lafuente; E Parellada
Journal:  Transl Psychiatry       Date:  2015-08-25       Impact factor: 6.222

10.  A Neuroanatomical Signature for Schizophrenia Across Different Ethnic Groups.

Authors:  Qiyong Gong; Paola Dazzan; Cristina Scarpazza; Kyioto Kasai; Xinyu Hu; Tiago R Marques; Norichika Iwashiro; Xiaoqi Huang; Robin M Murray; Shinsuke Koike; Anthony S David; Hidenori Yamasue; Su Lui; Andrea Mechelli
Journal:  Schizophr Bull       Date:  2015-08-11       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.